{"transactions":[{"id":3481039,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":156541,"kind":"person","name":"WHITCOMB RANDALL W","position":1,"cik":"0001218867","reported_name":"WHITCOMB RANDALL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T16:41:25.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":12000,"derivative":{"exercise_price":11.59,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-038489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218867/000120919119038489/doc4.xml","form_type":"4"}},{"id":3692699,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":156541,"kind":"person","name":"WHITCOMB RANDALL W","position":1,"cik":"0001218867","reported_name":"WHITCOMB RANDALL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-17T16:52:00.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":6000,"derivative":{"exercise_price":8.8,"expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-19-004246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218867/000120919119004246/doc4.xml","form_type":"4"}},{"id":3735274,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":156541,"kind":"person","name":"WHITCOMB RANDALL W","position":1,"cik":"0001218867","reported_name":"WHITCOMB RANDALL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-11T19:49:54.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":3720,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":3720,"derivative":{"exercise_price":16.4,"expiration_date":"2028-08-23","underlying":"Common Stock","underlying_shares":3720},"source":{"system":"sec-edgar","filing":"0001209191-18-062127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1218867/000120919118062127/doc4.xml","form_type":"4"}},{"id":3735273,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":156541,"kind":"person","name":"WHITCOMB RANDALL W","position":1,"cik":"0001218867","reported_name":"WHITCOMB RANDALL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-11T19:49:54.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":21438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Merger in exchange for a stock option to acquire 288,152 shares of Millendo common stock for $0.33 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":21438,"derivative":{"exercise_price":4.44,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":21438},"source":{"system":"sec-edgar","filing":"0001209191-18-062127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1218867/000120919118062127/doc4.xml","form_type":"4"}},{"id":3735272,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":156541,"kind":"person","name":"WHITCOMB RANDALL W","position":1,"cik":"0001218867","reported_name":"WHITCOMB RANDALL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-11T19:49:54.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":15784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 212,163 shares of Millendo Therapeutics, Inc. (\"Millendo\") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the \"Merger\")."}],"balance_after":15784,"source":{"system":"sec-edgar","filing":"0001209191-18-062127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1218867/000120919118062127/doc4.xml","form_type":"4"}}]}